Nomura Asset Management International’s Caris Life Sciences CAI Stock Holding History

Nomura Asset Management International’s Portfolio CAI Stock Details CAI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.41M	Buy	+247,605	New	+$4.43M	0.01%	879

Other funds holding CAI

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JHWEPV

J. H. Whitney Equity Partners VI New Canaan, Connecticut $201M AUM

Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

SSP

Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return

PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Nomura Asset Management International's CAI Position: Q2 2026 in Review

Nomura Asset Management International opened a new position in Caris Life Sciences (CAI) in Q2 2026: 247,605 shares worth $4.41M. The stake represents 0.01% of the portfolio and ranks #879 among its holdings.

246 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

Nomura Asset Management International held 247,605 shares of Caris Life Sciences worth $4.41M as of Q2 2026.
Caris Life Sciences was a new Nomura Asset Management International position in Q2 2026.
Caris Life Sciences made up 0.01% of Nomura Asset Management International's portfolio in Q2 2026, its #879 holding.
246 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on Nomura Asset Management International's 13F filing for Q2 2026, filed 14 Aug 2026.